Cargando…

Molecular targeted therapies for breast cancer treatment

Targeting the oestrogen receptor, HER2 (human epidermal growth factor receptor 2) and vascular endothelial growth factor has markedly improved breast cancer therapy. New targeted therapeutic approaches to induction of apoptosis or inhibition of anti-apoptosis, cell cycle progression, signal transduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlotter, Claus M, Vogt, Ulf, Allgayer, Heike, Brandt, Burkhard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575526/ https://www.ncbi.nlm.nih.gov/pubmed/18671839 http://dx.doi.org/10.1186/bcr2112

Ejemplares similares

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
por: Schlotter, Claus M, et al.
Publicado: (2003)

Viruses in colorectal cancer
por: Marongiu, Luigi, et al.
Publicado: (2021)

An Editorial View on the Special Issue “Colorectal Cancers: From Present Problems to Future Solutions”
por: Allgayer, Heike
Publicado: (2022)

Dietary Modulation of Bacteriophages as an Additional Player in Inflammation and Cancer
por: Marongiu, Luigi, et al.
Publicado: (2021)

The molecular genetics of breast cancer and targeted therapy
por: Suter, Rachel, et al.
Publicado: (2007)

Promising molecular targeted therapies in breast cancer
por: Munagala, Radha, et al.
Publicado: (2011)

Cetuximab and biomarkers in non-small-cell lung carcinoma
por: Patil, Nitin, et al.
Publicado: (2012)

MicroRNAs in the Regulation of MMPs and Metastasis
por: Abba, Mohammed, et al.
Publicado: (2014)

Molecular targeted therapy for the treatment of gastric cancer
por: Xu, Wenting, et al.
Publicado: (2016)

Medical Advances in Hepatitis D Therapy: Molecular Targets
por: Vogt, Amelie, et al.
Publicado: (2022)

MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer
por: Rusek, Anna Maria, et al.
Publicado: (2015)

Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis
por: Marongiu, Luigi, et al.
Publicado: (2022)

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

Current Molecular Combination Therapies Used for the Treatment of Breast Cancer
por: Wang, Yiling, et al.
Publicado: (2022)

MicroRNA Regulation of Epithelial to Mesenchymal Transition
por: Abba, Mohammed L., et al.
Publicado: (2016)

EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2022)

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease
por: Helms, M W, et al.
Publicado: (2008)

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
por: Toss, Angela, et al.
Publicado: (2017)

Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
por: Maennling, Amaia Eleonora, et al.
Publicado: (2019)

Molecular perspective on targeted therapy in breast cancer: a review of current status
por: Demir Cetinkaya, Busra, et al.
Publicado: (2022)

STAT3 pathway as a molecular target for resveratrol in breast cancer treatment
por: Kohandel, Zeynab, et al.
Publicado: (2021)

Down-regulation of E-cadherin is an essential event in activating β-catenin/Tcf dependent transcription and expression of its target genes in Pdcd4 knock-down cells
por: Wang, Qing, et al.
Publicado: (2009)

Molecular targeted therapy for anticancer treatment
por: Min, Hye-Young, et al.
Publicado: (2022)

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
por: Ramer, Robert, et al.
Publicado: (2021)

Personalized medicine-molecular targeted cancer therapy
por: Osamura, Robert Y, et al.
Publicado: (2009)

Differentially expressed microRNAs in colorectal cancer metastasis
por: Abba, Mohammed, et al.
Publicado: (2015)

CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models
por: Cremers, Natascha, et al.
Publicado: (2016)

RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
por: Haque, Sakib, et al.
Publicado: (2021)

Molecular characterization and targeted therapeutic approaches in breast cancer
por: Toss, Angela, et al.
Publicado: (2015)

An Insight into Molecular Targets of Breast Cancer Brain Metastasis
por: Kaleem, Mohammed, et al.
Publicado: (2022)

Apoptosis and Molecular Targeting Therapy in Cancer
por: Hassan, Mohamed, et al.
Publicado: (2014)

Molecular targeted therapy for advanced gastric cancer
por: Kim, Jong Gwang
Publicado: (2013)

Molecular Approaches To Target GPCRs in Cancer Therapy
por: Innamorati, Giulio, et al.
Publicado: (2011)

Roles of pathologists in molecular targeted cancer therapy
por: Osamura, Robert Y
Publicado: (2009)

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
por: Wilkes, Gail M.
Publicado: (2018)

miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
por: El-Daly, Sherien M., et al.
Publicado: (2016)

Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2021)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4nth7htf2lbsbt7ofj6ndvdu9